Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3901 AL 3915

Memantine overdose in a non-demented older adult

Safer U, Doruk H, Tasci I.

Geriatr Gerontol Int. 2015 Mar;15(3):383. doi: 10.1111/ggi.12375.

Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein

Lyoo CH, Ikawa M, Liow JS, Zoghbi SS, Morse CL, Pike VW, Fujita M, Innis RB, Kreisl WC.

J Nucl Med. 2015 May;56(5):701-6. doi: 10.2967/jnumed.114.146027. Epub 2015 Mar 12.

Ocular biomarkers of Alzheimer's disease

Heaton GR, Davis BM, Turner LA, Cordeiro MF.

Cent Nerv Syst Agents Med Chem. 2015;15(2):117-25. doi: 10.2174/1871524915666150319123015.

Cannabinoids in late-onset Alzheimer's disease

Ahmed A, van der Marck MA, van den Elsen G, Olde Rikkert M.

Clin Pharmacol Ther. 2015 Jun;97(6):597-606. doi: 10.1002/cpt.117. Epub 2015 Apr 17.

Advances in Alzheimer's disease: from bench to bedside

Jiang T, Chang RC, Rosenmann H, Yu JT.

Biomed Res Int. 2015;2015:202676. doi: 10.1155/2015/202676. Epub 2015 Feb 19.

[Dementia: an interdisciplinary challenge!]

Kressig RW.

Ther Umsch. 2015 Apr;72(4):211. doi: 10.1024/0040-5930/a000666.

[Dementia of the Alzheimer type: non-drug and drug therapy]

Kressig RW.

Ther Umsch. 2015 Apr;72(4):233-8. doi: 10.1024/0040-5930/a000670.

[Judgment capacity from the legal viewpoint - especially the evaluation by a notary public]

Wolf S, Nuspliger I.

Ther Umsch. 2015 Apr;72(4):247-53. doi: 10.1024/0040-5930/a000672.

[Behavioral and psychological symptoms of dementia (BPSD): how to proceed]

Savaskan E.

Ther Umsch. 2015 Apr;72(4):255-60. doi: 10.1024/0040-5930/a000673.

[Possibilities of modern imaging technologies in early diagnosis of Alzheimer disease]

Unschuld PG.

Ther Umsch. 2015 Apr;72(4):261-9. doi: 10.1024/0040-5930/a000674.

[(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease

Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, Hiraoka K, Watanuki S, Shidahara M, Miyake M, Ishikawa Y, Matsuda R, Inami A, Yoshikawa T, Tago T, Funaki Y, Iwata R, Tashiro M, Yanai K, Arai H, Kudo Y.

Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1052-61. doi: 10.1007/s00259-015-3035-4. Epub 2015 Mar 20.

Tailored nutritional guidance for home-dwelling AD families: the Feasibility of and Elements Promoting Positive Changes in Diet (NuAD-Trial)

Puranen TM, Pitkala KH, Suominen MH.

J Nutr Health Aging. 2015 Apr;19(4):454-9. doi: 10.1007/s12603-014-0567-4.

Mouse brain magnetic resonance microscopy: Applications in Alzheimer disease

Lin L, Fu Z, Xu X, Wu S.

Microsc Res Tech. 2015 May;78(5):416-24. doi: 10.1002/jemt.22489. Epub 2015 Mar 21.

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study

Sabri O, Sabbagh MN, Seibyl J, Barthel H, Akatsu H, Ouchi Y, Senda K, Murayama S, Ishii K, Takao M, Beach TG, Rowe CC, Leverenz JB, Ghetti B, Ironside JW, Catafau AM, Stephens AW, Mueller A, Koglin N, Hoffmann A, Roth K, Reininger C, Schulz-Schaeffer WJ; Florbetaben Phase 3 Study Group.

Alzheimers Dement. 2015 Aug;11(8):964-74. doi: 10.1016/j.jalz.2015.02.004. Epub 2015 Mar 28.

Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function

Hertz L, Chen Y, Waagepetersen HS.

J Neurochem. 2015 Jul;134(1):7-20. doi: 10.1111/jnc.13107. Epub 2015 Apr 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias